These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2419929)

  • 21. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK; Kirstein M
    J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interval- and voltage-dependent effects of the calcium channel-blocking agents D600 and AQA 39 on mammalian ventricular muscle.
    Trautwein W; Pelzer D; McDonald TF
    Circ Res; 1983 Feb; 52(2 Pt 2):I60-8. PubMed ID: 6299606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
    Poppe H; Femmer K; Kaverina NV; Lyskovzev VV; Grigoreva JK; Mazievskij DD
    Pharmazie; 1985 Dec; 40(12):857-61. PubMed ID: 3841603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antifibrillatory and anti-arrhythmic action of 3-carbethoxyamino-5-dimethylamino-acetyl iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) on models of myocardial ischemia].
    Kaverina NV; Lyskovzev VV; Grigoreva JK; Senova ZP; Sulakvelidze MT; Grizenko AN
    Pharmazie; 1985 Dec; 40(12):845-7. PubMed ID: 3841599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A; Pytkowski B; Sedek G; Zdanowski K
    Pol J Pharmacol Pharm; 1983; 35(3):223-32. PubMed ID: 6651921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency- and voltage-dependent effects of recainam on the upstroke velocity of action potential in rabbit ventricular muscle.
    Kamiya K; Takikawa R; Singh BN
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):630-7. PubMed ID: 2471002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rate, rhythm and voltage dependent effects of phenytoin: a test of a model of the mechanisms of action of antiarrhythmic drugs.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1978; 21():63-5. PubMed ID: 693541
    [No Abstract]   [Full Text] [Related]  

  • 29. 5-Hydroxytryptamine antagonist ICS 205-930 blocks cardiac potassium, sodium and calcium currents.
    Scholtysik G; Imoto Y; Yatani A; Brown AM
    J Pharmacol Exp Ther; 1988 Jun; 245(3):773-8. PubMed ID: 2455036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate rhythm and voltage dependent effects of aprindine: a test of a model of the mechanisms of action of antiarrhythmic drugs.
    Moyer JW; Hondeghem LM
    Proc West Pharmacol Soc; 1978; 21():57-61. PubMed ID: 693540
    [No Abstract]   [Full Text] [Related]  

  • 31. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers.
    Cohen CJ; Bean BP; Tsien RW
    Circ Res; 1984 Jun; 54(6):636-51. PubMed ID: 6329543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of bonnecor on transmembrane potentials of cardiomyocytes of the ventricular contractile myocardium of the intact heart and ventricular fibrillation].
    Kobrin VI; Vostrikov VA
    Kardiologiia; 1992 Jun; 32(6):61-3. PubMed ID: 1405299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Ni2+ on the fast sodium channels in frog myocardium].
    Mukumov MR; Khodorov BI
    Dokl Akad Nauk SSSR; 1978; 241(6):1475-7. PubMed ID: 710253
    [No Abstract]   [Full Text] [Related]  

  • 35. Electropharmacology of Ro 22-9194, a new antiarrhythmic agent.
    Kodama I; Maruyama K; Suzuki R; Honjo H; Toyama J
    Gen Pharmacol; 1996 Jul; 27(5):755-60. PubMed ID: 8842676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of the antifibrillatory action of Chinoin-103, a new antiarrhythmic drug.
    Mészáros J; Korbonits D; Kovács G; Szegi J
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):268-81. PubMed ID: 2421658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of the action of class I antiarrhythmic drugs (lidocaine, quinidine, and prajmaline) in rabbit atrial and ventricular myocardium.
    Langenfeld H; Weirich J; Köhler C; Kochsiek K
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):338-45. PubMed ID: 1689432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrophysiologic research on the anti-arrhythmia properties of bonnecor--a new dibenzazepine derivative].
    Berdiaev SIu; Marko R; Kelemen K; Darinskiĭ NV; Kaverina NV
    Kardiologiia; 1986 Aug; 26(8):16-9. PubMed ID: 3531669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative study of the pharmacokinetics and pharmacodynamics of bonnecor].
    Rodionov AP; Lyskovtsev VV; Ignatova NA; Tolmacheva EA; Grigor'eva EK; Belinskiaia GF; Sheĭnberg BV
    Farmakol Toksikol; 1990; 53(3):40-3. PubMed ID: 1696909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle.
    Courtney KR
    Eur J Pharmacol; 1981 Aug; 74(1):9-18. PubMed ID: 6274652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.